Background Image
Table of Contents Table of Contents
Previous Page  23 / 78 Next Page
Information
Show Menu
Previous Page 23 / 78 Next Page
Page Background

117

Ces Urol 2015; 19(2): 106–117

PŘEHLEDOVÝ ČLÁNEK

26. Castle SM, Gorbatiy V, Ekwenna O, Young E, Leveillee RJ.

Radiofrequency ablation (RFA) therapy for

renal angiomyolipoma (AML): an alternative to angio-embolization and nephron-sparing surgery. BJU Int.

2012; 109(3): 384–387.

27. Morávek P jr, Morávek P, Dvořák P.

Perkutánní radiofrekvenční ablace (RFA) v léčbě nádorů ledvin –

vlastní zkušenosti. Ces Urol 2010; 14(2): 104–109.

28. Jacomides L, Ogan K, Watumull L, Cadeddu JA.

Laparoscopic application of radio frequency energy

enables in situ renal tumor ablation and partial nephrectomy. J Urol. 2003; 169(1): 49–53.

29. Davenport MS, Cavili EM, Cohan RH, et al.

MRI and CT characteristics of success fully ablated renal

masses: Imaging surveillance after radiofrequency ablation. ARJ AM J Roentgenol 2009; 192(6): 1571–1578.

30. Klingler HC, Marberger M, Mauermann J, et al.

‘Skipping’ is still a problem with radiofrequency ab-

lation of small renal tumours. BJU Int 2007; 99: 998–1001.

31. Delworth MG, Pisters LL, Fornage BD, von Eschenbach AC.

Cryotherapy for renal cell carcinoma and

angiomyolipoma. J Urol. 1996; 155(1): 252–254.

32. Johnson SC, Graham S, D’Agostino H, Elmajian DA, Shingleton WB.

Percutaneous renal cryoablation

of angiomyolipomas in patients with solitary kidneys. Urology. 2009; 74(6): 1246–1249.

33. Byrd GF, Lawatsch EJ, Mesrobian HG, Begun F, Langenstroer P.

Laparoscopic cryoablation of renal

angiomyolipoma. J Urol. 2006; 176 (4 Pt 1): 1512–1516.

34. Weight CJ, Kaouk JH, Hegarty NJ, et al.

Correlation of radiographic imaging and histopathology

following cryoablation and radio frequency ablation for renal tumors. J Urol 2008; 179(4): 1277–1281.

35. Kunkle DA, Egleston BL, Uzzo RG.

Excise, ablate or observe: the small renal mass dilemma – a meta-

-analysis and review. J Urol 2008; 179 (4): 1227–1233.

36. Boorjian SA, Frank I, Inman B, Lohse Ch M, Cheville JC, et al.

The Role of Partial Nephrectomy for the

Management of Sporadic Renal Angiomyolipoma. UROLOGY 2007; 70: 1064–1068.

37. Heidenreich A, Hegele A, Varga Z, vonKnobloch R, Hofmann R.

Nephron sparing surgery for renal

angiomyolipoma. Eur Urol 2002; 41: 267–273.

38. Čermák A, Pacík D, Vít V.

Současný pohled na léčbu malých nádorů ledvin. Urol List 2012; 10(3): 6–15.

39. Hora M, Eret V, Ürge T, et al.

Results of laparoscopic resection of kidney tumour in everyday clinical

practice, CEJU (Central European Journal of Urology), 2009, 62(3): 160–166.

40. Msezane L, Chang A, Shikanov S, et al.

Laparoscopic nephronsparing surgery in the management

of angiomyolipoma: a single center experience. J Endourol. 2010; 24(4): 583–587.

41. Simmons MN, Chung BI, Gill IS.

Perioperative efficacy of laparoscopic partial nephrectomy for tumors

larger than 4 cm. Eur Urol. 2009; 55(1): 199–207.

42. Lane BR, Aydin H, Danforth TL, et al.

Clinical correlates of renal angiomyolipoma subtypes in 209

patients: classic, fat poor, tuberous sclerosis associated and epithelioid. J Urol. 2008; 180(3): 836–843.

43. Schips L, Berardinelli F, Neri F, Tamburro FR, Cindolo L.

Laparoendoscopic single-site partial nephrectomy

without ischemia for very small, exophytic renal masses: surgical details and functional outcomes. Eur Urol. 2012.

44. Bolufer E, López-Fontana G, Castillo OA.

Robot assisted partial nephrectomy (Da Vinci) in an angio-

myolipoma associated to Wünderlich Syndrome. Arch Esp Urol. 2012; 65(9): 831–834.

45. El-Hashemite N, Walker V, Zhang H, Kwiatkowski DJ.

Loss of Tsc1 or Tsc2 induces vascular endothelial

growth factor production through mammalian target of rapamycin. Cancer Res. 2003; 63(17): 5173–5177.

46. Dabora SL, Franz DN, Ashwal S, et al.

Multicenter phase 2 trial of sirolimus for tuberous sclerosis:

kidney angiomyolipomas and other tumors regress and. PLoS One. 2011; 6(9): e23379.

47. Bissler JJ, Kingswood JC, Radzikowska E, et al.

Everolimus for angiomyolipoma associated with

tuberous sclerosis complex or sporadic lymphangioleiomyomatosis (EXIST-2): a multicentre, randomised,

double-blind, placebo-controlled trial. 1. Lancet. 2013 Mar 9; 381(9869): 817.

48. Staehler M, Sauter M, Helck A, et al.

Nephron-sparing resection of angiomyolipoma after sirolimus

pretreatment in patients with tuberous sclerosis. Int Urol Nephrol 2012 Dec; 44 (6): 1657–1661.